These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


359 related items for PubMed ID: 32366182

  • 1. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM, Book T, Manns MP, von Hahn T, Voigtländer T.
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [Abstract] [Full Text] [Related]

  • 2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW.
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications.
    Voigtländer T, Jaeckel E, Lehner F, Manns MP, Lankisch TO.
    Liver Transpl; 2015 Oct; 21(10):1295-9. PubMed ID: 26069199
    [Abstract] [Full Text] [Related]

  • 4. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S, Veltzke-Schlieker W, Adler A, Schott E, Eurich D, Faber W, Neuhaus P, Seehofer D.
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [Abstract] [Full Text] [Related]

  • 5. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
    Leonhardt S, Veltzke-Schlieker W, Adler A, Schott E, Hetzer R, Schaffartzik W, Tryba M, Neuhaus P, Seehofer D.
    Crit Care; 2015 Mar 31; 19(1):131. PubMed ID: 25886728
    [Abstract] [Full Text] [Related]

  • 6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM, International PSC Study Group.
    Gastroenterology; 2017 Jun 31; 152(8):1975-1984.e8. PubMed ID: 28274849
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
    de Vries EMG, Färkkilä M, Milkiewicz P, Hov JR, Eksteen B, Thorburn D, Chazouillères O, Pares A, Nygård S, Gilja OH, Wunsch E, Invernizzi P, Carbone M, Bernuzzi F, Boberg KM, Røsjø H, Rosenberg W, Beuers UH, Ponsioen CY, Karlsen TH, Vesterhus M.
    Liver Int; 2017 Oct 31; 37(10):1554-1561. PubMed ID: 28267887
    [Abstract] [Full Text] [Related]

  • 10. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
    de Vries EM, de Krijger M, Färkkilä M, Arola J, Schirmacher P, Gotthardt D, Goeppert B, Trivedi PJ, Hirschfield GM, Ytting H, Vainer B, Buuren HR, Biermann K, Harms MH, Chazouilleres O, Wendum D, Kemgang AD, Chapman RW, Wang LM, Williamson KD, Gouw AS, Paradis V, Sempoux C, Beuers U, Hübscher SG, Verheij J, Ponsioen CY.
    Hepatology; 2017 Mar 31; 65(3):907-919. PubMed ID: 27880989
    [Abstract] [Full Text] [Related]

  • 11. Primary sclerosing cholangitis: liver transplantation or biliary surgery.
    Farges O, Malassagne B, Sebagh M, Bismuth H.
    Surgery; 1995 Feb 31; 117(2):146-55. PubMed ID: 7846618
    [Abstract] [Full Text] [Related]

  • 12. Secondary sclerosing cholangitis following major burn.
    Ben-Ari Z, Levingston D, Weitzman E, Haviv-Yadid Y, Cohen-Ezra O, Weiss P, Zuckerman E, Inbar Y, Amitai M, Rimon U, Goder M, Haik J.
    Ann Hepatol; 2015 Feb 31; 14(5):695-701. PubMed ID: 26256898
    [Abstract] [Full Text] [Related]

  • 13.  Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.
    Hilscher M, Enders FB, Carey EJ, Lindor KD, Tabibian JH.
    Ann Hepatol; 2016 Feb 31; 15(2):246-53. PubMed ID: 26845602
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
    Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I.
    Liver Transpl; 2008 Feb 31; 14(2):181-5. PubMed ID: 18236392
    [Abstract] [Full Text] [Related]

  • 16. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep 31; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 17. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
    Voigtländer T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, Lankisch TO.
    Endoscopy; 2012 Nov 31; 44(11):1055-8. PubMed ID: 23108773
    [Abstract] [Full Text] [Related]

  • 18. Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease.
    Navaneethan U, G K Venkatesh P, Lashner BA, Lopez R, Kiran RP, Shen B.
    J Crohns Colitis; 2012 Jul 31; 6(6):674-80. PubMed ID: 22398102
    [Abstract] [Full Text] [Related]

  • 19. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U, Venkatesh PG, Lashner BA, Shen B, Kiran RP.
    Aliment Pharmacol Ther; 2012 May 31; 35(9):1045-53. PubMed ID: 22428605
    [Abstract] [Full Text] [Related]

  • 20. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
    Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H.
    Clin Transl Gastroenterol; 2021 Mar 01; 12(3):e00315. PubMed ID: 33646203
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.